Mizuho Medy Co.,Ltd.

Tokyo Stock Exchange 4595.T

Mizuho Medy Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 71.83 M

Mizuho Medy Co.,Ltd. Cash and Short-Term Investments is USD 71.83 M for the year ending December 31, 2023, a 8.26% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Mizuho Medy Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 66.35 M, a 76.54% change year over year.
Mizuho Medy Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 37.58 M, a 7,050.33% change year over year.
Mizuho Medy Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 525.58 K, a -73.70% change year over year.
Mizuho Medy Co.,Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 2.00 M, a -6.89% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Tokyo Stock Exchange: 4595.T

Mizuho Medy Co.,Ltd.

CEO	Mr. Fuminari Karakawa
IPO Date	Dec. 18, 2015
Location	Japan
Headquarters	5-4 Fujinoki-machi
Employees	180
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.

Key trends

Past 5 years